“The accuracy and safety of the technology, used by our solutions, has been validated in clinical pilots,” says Jokke Mäki, CEO of GlucoModicum.
How does it all work, then? – GlucoModicum’s proprietary magnetohydrodynamics (MHD) technology allows for needle-free measuring of glucose levels from the skin, explains Mäki.
“The first solution has been created for needle-free glucose monitoring, but the needle-free approach can obviously be used in connection to various forms of treatment,” he adds.
According to Mäki, blood glucose monitoring is essential for the diagnosis and management of diabetes, but there are no needle-free glucose monitoring solutions on the market right now.
“The currently available invasive technologies can be both painful and time-consuming – and, what’s more, they can lead to extreme glucose levels remaining unnoticed, as people do not want to stick needles in their body for the purpose of monitoring their health,” Mäki says.